Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
CR-CP Life Science Fund
AddedMar 20, 2024
UpdatedJun 28, 2026
CR-CP Life Science Fund

CR-CP Life Science Fund

Operating

Rhode Island medical organization investing in life science innovations.

Location
Rhode Island, US
Firm
Compare
Portfolio
Employees

CR-CP Life Science Fund is a joint venture set up by China Resources Group and Charoen Pokphand Group.

This firm invests in life science companies that develop drugs, cell therapies, medical devices, and smart healthcare technology.

CR-CP Life Science Fund - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments2
Current Portfolio Count2
Total Portfolio Exits0

Top Investment Stages

Series B1 (50.0%)
Series C1 (50.0%)

Stage Mix

Series B 50%Series C 50%

Concentration shown as share of disclosed investments by stage.

Recent Investments

NuProbe logo

NuProbe

Sirnaomics logo

Sirnaomics

CR-CP Life Science Fund - Similar Investment Firms

Charter Life Sciences logo

Charter Life Sciences

Perceptive Life Sciences logo

Perceptive Life Sciences

CRG logo

CRG

crglp.com

CR Ventures logo

CR Ventures

cr-ventures.com

Cenova Capital logo

Cenova Capital

Cr-Cct Industry Pilot Fund logo

Cr-Cct Industry Pilot Fund

Acorn Bioventures logo

Acorn Bioventures

Pacific Rim Ventures logo

Pacific Rim Ventures

WuXi Healthcare Ventures logo

WuXi Healthcare Ventures

Caxton Advantage Life Sciences Fund logo

Caxton Advantage Life Sciences Fund

China BioPharma Capital I logo

China BioPharma Capital I

Chione logo

Chione

Cogene Ventures logo

Cogene Ventures

Nan Fung Life Sciences logo

Nan Fung Life Sciences

CTI Life Sciences Fund logo

CTI Life Sciences Fund

ctisciences.com

CR-CP Life Science Fund - Classification

NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 2 more industry codes
NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions